Lombard Odier Asset Management (Europe) LTD Silence Therapeutics PLC Transaction History
Lombard Odier Asset Management (Europe) LTD
- $1.08 Billion
- Q1 2024
A detailed history of Lombard Odier Asset Management (Europe) LTD transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Lombard Odier Asset Management (Europe) LTD holds 2,238,039 shares of SLN stock, worth $44.6 Million. This represents 4.48% of its overall portfolio holdings.
Number of Shares
2,238,039
Previous 3,612,877
38.05%
Holding current value
$44.6 Million
Previous $62.8 Million
22.97%
% of portfolio
4.48%
Previous 5.06%
Shares
9 transactions
Others Institutions Holding SLN
# of Institutions
63Shares Held
27.1MCall Options Held
0Put Options Held
0-
Tcg Crossover Management, LLC Palo Alto, CA3.3MShares$65.7 Million7.49% of portfolio
-
Artal Group S.A. Luxembourg, N42.78MShares$55.5 Million3.24% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY2.39MShares$47.7 Million1.25% of portfolio
-
Redmile Group, LLC San Francisco, CA2.03MShares$40.5 Million1.73% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.64MShares$32.8 Million1.17% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $716M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...